Affiliations 

  • 1 Department of Electrical Engineering, Faculty of Engineering, Universiti Malaya, Kuala Lumpur50603, Malaysia
  • 2 Centre of Printable Electronics, Universiti Malaya, Kuala Lumpur50603, Malaysia
  • 3 Department of Biomedical Engineering, Faculty of Engineering, Universiti Malaya, Kuala Lumpur50603, Malaysia
  • 4 Institute of Advanced Materials and Technology, Guangdong University of Technology, Guangzhou510006, China
  • 5 School of Engineering, Faculty of Innovation and Technology, Taylor's University, Subang Jaya, Selangor47500, Malaysia
  • 6 Faculty of Science, Institute of Mathematical Sciences, Universiti Malaya, Kuala Lumpur50603, Malaysia
  • 7 Institute of Advanced Studies, Universiti Malaya, Kuala Lumpur50603, Malaysia
ACS Sens, 2026 Oct 23;11(10):8813-8838.
PMID: 42864835 DOI: 10.1021/acssensors.6c02471

Abstract

Wearable glucose sensors enable continuous monitoring of glycemic dynamics, yet their clinical utility is constrained by signal instability, physiological delay, and limited predictive capability. Artificial intelligence (AI) has been increasingly integrated to address these limitations. This review summarizes recent advances in AI-enhanced wearable glucose sensors, with a focus on the evolution of sensing technologies and the role of AI across three main aspects: calibration, glucose prediction, and wearable closed-loop control. In calibration, AI-based approaches for improving short-term signal reliability and compensating long-term drift are reviewed. In prediction, methods ranging from continuous glucose monitoring (CGM)-based forecasting to multimodal sensor fusion and noninvasive sensing are summarized, including both continuous glucose estimation and event-oriented detection of hypo- and hyperglycemia. The integration of sensing, prediction, and insulin delivery in wearable closed-loop artificial pancreas is also discussed. Finally, the remaining challenges and future directions are discussed, highlighting the potential of AI-enhanced wearable glucose sensors to support more reliable and integrated diabetes management.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.